Poland: A Thriving Hub for Biotech Advancements and Clinical Trials Poland has emerged as a leading destination for biotech professionals seeking a dynamic and conducive environment for conducting clinical trials. With its robust healthcare infrastructure, highly skilled workforce, supportive regulatory framework, and favorable economic conditions, Poland offers a compelling landscape for biotech advancements. This article aims to delve into the key factors that have made Read more
ASCO Key Takeaways, ASCO Annual Meeting, ASCO 2023
Insights from ASCO 2023 Cromos Pharma’s CEO, Vlad Bogin, recently attended the 58th meeting of the American Society of Clinical Oncology (ASCO). Vlad took part in discussions with key opinion leaders about current clinical research trends and held a significant number of meetings with biotech and pharma stakeholders to discuss their development programs.  Here are Vlad’s key takeaways from this Read more
Clinical Research Focus. 17th Edition The Pros and Cons of the FDAs Real-Time Oncology Review Program The FDA’s Real-Time Oncology Review (RTOR) is a novel program designed to expedite the review of new cancer therapies. Since its inception the program has gained considerable attention among biotech professionals, especially those working in the field of oncology. Under the RTOR program, the FDA accepts Read more
Clinical Trials in the Baltic States – Countries’ Profile for 2023 In recent years the Baltic States, comprised of Estonia, Latvia and Lithuania, have become a formidable destination for conducting clinical trials due to its mature healthcare systems and rational regulatory reforms. On the one hand, the Baltic states abide by the same international standards and agreements as other EU countries, and, on the other, the Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us